During this extended interval, you may experience some reduction in glycaemic control, though the medication's long half-life means you will still have some circulating semaglutide providing therapeutic benefit
Other GLP-1 receptor agonists available in the UK include dulaglutide (Trulicity), liraglutide (Victoza), exenatide (Byetta, Bydureon), and tirzepatide (Mounjaro), which share similar mechanisms of action but differ in dosing frequency and pharmacokinetic profiles
Gradual Weight Loss Research has shown that using tirezpatide at the current therapeutic dose (5 mg+) leads to substantial weight loss
(1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome Nature 385(6612):165168
If your primary concern is metabolic health, blood sugar regulation, and exercise performance, MOTS-C may be the better fit
Stay Connected with Portrait Care Subscribe to our email list and receive the latest insights, updates, and exclusive content delivered straight to your inbox.